The discovery and development of small molecule immune potentiators (SMIPs) as next-generation vaccine adjuvants, the creation of AS37
{{output}}
Aluminum salts remain the most widely used adjuvants in licensed vaccines, but their tendency to favor Th2-dominant humoral responses limits their usefulness when robust Th1, T follicular helper (Tfh), and cellular responses are required. Small-molecule immune... ...
